Efficacy And Safety Of Tofacitinib In Chinese Subjects With Active Psoriatic Arthritis
Status:
Completed
Trial end date:
2021-04-28
Target enrollment:
Participant gender:
Summary
This is a 6 month study investigating the effectiveness and safety of tofacitinib in treating
signs and symptoms and improving physical function in Chinese patients with active psoriatic
arthritis and had inadequate response to a conventional synthetic disease modifying
anti-rheumatic drug. This is a China alone study.